Doxil and Toxic neuropathy - a phase IV clinical study of FDA data

Summary:

Toxic neuropathy is reported as a side effect among people who take Doxil (doxorubicin hydrochloride), especially for people who are female, 40-49 old, also take Diflucan, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Toxic neuropathy when taking Doxil. It is created by eHealthMe based on reports of 10,418 people who have side effects when taking Doxil from the FDA, and is updated regularly.

What is Doxil?

Doxil has active ingredients of doxorubicin hydrochloride. It is often used in ovarian cancer. eHealthMe is studying from 10,479 Doxil users. Check the latest studies of Doxil.

What is Toxic neuropathy?

Toxic neuropathy (nerve damage caused by toxic (harmful) substances) is found to be associated with 64 drugs and 177 conditions by eHealthMe. Check the latest studies of Toxic neuropathy.

On Jul, 09, 2026

10,418 people reported to have side effects when taking Doxil.
Among them, 13 people (0.12%) have Toxic neuropathy.

Among these 13 people:

What is the gender of people who have Toxic neuropathy when taking Doxil? *

female: 100 %
male: 0.0 %

What is the age of people who have Toxic neuropathy when taking Doxil? *

What are other drugs people take besides Doxil? *

What are other side effects people have besides Toxic neuropathy? *

Thrombocytopenia (decrease of platelets in blood): 13 people, 100.00%
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 13 people, 100.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 13 people, 100.00%
Mouth Ulcers: 13 people, 100.00%
Leukaemia (blood or bone marrow cancer): 13 people, 100.00%
Congestive Cardiomyopathy (weakening of heart muscle): 13 people, 100.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 13 people, 100.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 13 people, 100.00%
Refractory Anaemia With An Excess Of Blasts (one or more cell types are low in the blood and look abnormal in the bone marrow): 11 people, 84.62%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 10 people, 76.92%

What are the existing conditions these people have? *

Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 13 people, 100.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 13 people, 100.00%
Refractory Anaemia With An Excess Of Blasts (one or more cell types are low in the blood and look abnormal in the bone marrow): 12 people, 92.31%
Mouth Ulcers: 3 people, 23.08%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 23.08%
Diffuse Large B-Cell Lymphoma Stage I (cancer of b cells, a type of white blood cell- stage i): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Doxil and have Toxic neuropathy?

- Check whether Toxic neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doxil:

Doxil (10,479 reports)

Browse all side effects of Doxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toxic neuropathy:

Toxic neuropathy (64 drugs)

Browse all the conditions that are associated with Toxic neuropathy:

Toxic neuropathy (177 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Doxil) and Doxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.